Evolution into a Healthcare Company Driven by the Yakult Group Global Vision 2030
First written in FY2021. 8 of 10 entries say "Restated". Latest entry: 2026-05-12.
No other company in this theme has enough history to compare yet.
- 2026-05-12RestatedEarnings
「Based on the long-term vision Yakult Group Global Vision 2030, we worked to improve results by pursuing our goal of becoming a healthcare company that continues to contribute to the health of people worldwide and conducting corporate activities based on the medium-term management plan (2025-2030).」
The company continues to pursue its direction of becoming a healthcare company based on Yakult Group Global Vision 2030. - FY2026-H1RestatedAnnual report
「In addition, based on the long-term vision, Yakult Group Global Vision 2030, the company aims to become a healthcare company that continues to contribute to the health of people worldwide, while」
The company continues to pursue its direction of becoming a healthcare company based on Yakult Group Global Vision 2030. - FY2025-H1RestatedAnnual report
「In addition, based on the long-term vision, Yakult Group Global Vision 2030, the company pursued its business activities and worked to improve performance with the aim of becoming a healthcare company that continues to contribute to the health of people worldwide.」
The company continues to pursue its direction of becoming a healthcare company based on Yakult Group Global Vision 2030. - FY2024-Q3RestatedAnnual report
「In addition, based on the long-term vision, Yakult Group Global Vision 2030, the company pursued its business activities and worked to improve performance with the aim of becoming a healthcare company that continues to contribute to the health of people worldwide.」
The company continues to pursue its direction of becoming a healthcare company based on Yakult Group Global Vision 2030. - FY2024-Q2RestatedAnnual report
「In addition, based on the long-term vision, Yakult Group Global Vision 2030, the company pursued its business activities and worked to improve performance with the aim of becoming a healthcare company that continues to contribute to the health of people worldwide.」
The company continues to pursue its direction of becoming a healthcare company based on Yakult Group Global Vision 2030. - FY2024-Q1RestatedAnnual report
「In addition, based on the long-term vision, Yakult Group Global Vision 2030, the company pursued its business activities and worked to improve performance with the aim of becoming a healthcare company that continues to contribute to the health of people worldwide.」
The company continues to pursue its direction of becoming a healthcare company based on Yakult Group Global Vision 2030. - FY2023RestatedAnnual report
「<Quantitative targets> (Fiscal 2030 targets) Global dairy product volume: 52.5 million bottles/day (Japan: 10.5 million bottles/day; overseas: 42.0 million bottles/day) Consolidated net sales: ¥550 billion Consolidated operating profit: ¥80 billion (operating margin: 14.5%)」
The company continues to set long-term targets for global milk-product unit sales, revenue, operating profit and operating margin for FY2030. - FY2022RestatedAnnual report
「Toward fiscal 2030, the Company will continue growing the overseas beverages and food manufacturing and sales business while further improving the profitability of the Japan beverages and food manufacturing and sales business, thereby increasing global dairy product volumes, consolidated net sales and consolidated operating profit.」
For Yakult Group Global Vision 2030, the Company continues to identify deepening and expanding overseas operations, improving profitability in Japan, developing new growth models and expanding healthcare-related areas as means of achieving the vision. - FY2022-Q1AdvancedAnnual report
「From the first quarter of the current consolidated fiscal year, the Company reviewed the content of corporate expenses based on the long-term vision formulated during the current fiscal year and changed the allocation so that part of these expenses is allocated to business segments.」
Based on the newly formulated long-term vision, the Company reviewed the content of corporate expenses and began allocating part of them to business segments from the first quarter of the current fiscal year. - FY2021First statedAnnual report
「To maintain the growth of the Yakult Group and respond to change, the Company formulated the long-term vision “Yakult Group Global Vision 2030,” covering fiscal 2021 through fiscal 2030.」
The Company has set its vision as “evolving into a healthcare company that continues to contribute to the health of people around the world,” with fiscal 2030 targets of average global daily dairy product sales of 52.5 million bottles, consolidated net sales of ¥550 billion, consolidated operating profit of ¥80 billion and an operating margin of 14.5%.